MedTrace Logo

The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract Diseases

NCT05896956 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-06-09

No results posted yet for this study

Summary

The aim of the study is to establishing a standardized biobank and a clinical information database for patients with benign and malignant tumors of the biliary system. With follow-up plans and advanced multiomics technology, a multiomics database for patients with benign and malignant tumors of the biliary tract will be further established. Based on the above work, real-world clinical research on the diagnosis and treatment of biliary tract tumors is about to be carried out, and a high-standard cohort research foundation is laid for precision therapy based on multiomics characteristics and molecular typing of biliary tract tumors.

Conditions

  • Biliary Tract Diseases
  • Gallbladder Cancer
  • Extrahepatic Bile Duct Cancer
  • Intrahepatic Cholangiocarcinoma
  • Biliary Tract Neoplasms
  • Gall Stone

Interventions

OTHER

no interventions

no interventions

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Ying-Bin Liu, PhD · RenJi Hospital

Eligibility

Min Age
18 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2027-06-30
Completion
2027-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05896956 on ClinicalTrials.gov